Depression in Parkinson's disease is not accompanied by more corticotropin-releasing hormone expressing neurons in the hypothalamic paraventricular nucleus.
BACKGROUND
Depression is frequently encountered in Parkinson's disease (PD). In addition, more than half of the PD patients have a disturbed dexamethasone suppression test, which is associated with increased activity of corticotropin-releasing hormone (CRH) neurons. We recently found an increase in CRH neuron number, CRH-messenger RNA, and vasopressin colocalization in CRH neurons in the paraventricular nucleus (PVN) of depressed patients, which may be involved in the pathogenesis of depression.


METHODS
The number of neurons expressing CRH was determined in the PVN of 6 depressed PD patients with a high score (> or = 13) on the Hamilton Depression Rating Scale, 6 nondepressed PD patients, and 6 controls.


RESULTS
The three groups did not differ in the number of neurons expressing CRH.


CONCLUSIONS
We hypothesize that activation of CRH neurons in the PVN, as we recently observed in idiopathic depression, does not play an essential role in depression in PD.
Hoogendijk
W J
WJ
Graduate School Neurosciences Amsterdam, Netherlands Institute for Brain Research, The Netherlands.
Purba
J S
JS
Hofman
M A
MA
de Vos
R A
RA
Jansen
E N
EN
Swaab
D F
DF
D000368:Aged; D000369:Aged, 80 and over; D003346:Corticotropin-Releasing Hormone / Q000096:biosynthesis*; D003863:Depression / Q000150:complications* / Q000378:metabolism / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009474:Neurons / Q000378:metabolism*; D010286:Paraventricular Hypothalamic Nucleus / Q000378:metabolism* / Q000473:pathology*; D010300:Parkinson Disease / Q000150:complications* / Q000378:metabolism / Q000473:pathology*
D003346:Corticotropin-Releasing Hormone